ANI PHARMACEUTICALS INC 8-K

What Happened
ANI Pharmaceuticals, Inc. announced on its Form 8‑K that it notified EisnerAmper LLP of its dismissal as the Company’s independent registered public accounting firm, effective April 1, 2026. The Audit and Finance Committee approved the decision. The company filed the 8‑K on April 7, 2026; the filing was signed by SVP Finance and CFO Stephen P. Carey.

Key Details

• Date of dismissal: April 1, 2026; 8‑K filed April 7, 2026.
• Audit Committee approved the dismissal.
• EisnerAmper’s audit reports for fiscal years ended Dec 31, 2025 and Dec 31, 2024 contained no adverse opinions or disclaimers and were not qualified or modified.
• EisnerAmper reported no disagreements or “reportable events” with the company for 2024, 2025 or through April 1, 2026.
• Exhibit filed: Letter from EisnerAmper LLP dated April 7, 2026 (Exhibit 16.1).

Why It Matters
A change in independent auditor is a material corporate action investors watch because it affects the firm responsible for auditing financial statements. In this case, the filing states there were no audit disagreements or reportable events and prior audit reports were clean, which suggests the transition was routine rather than prompted by a dispute over accounting or disclosures. Investors should note the change and look for the identity of the successor auditor in future filings and for any related disclosures in upcoming periodic reports.